Page last updated: 2024-11-05

zonisamide and Binge-Eating Disorder

zonisamide has been researched along with Binge-Eating Disorder in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Binge-Eating Disorder: A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marazziti, D2
Rossi, L1
Baroni, S2
Consoli, G2
Hollander, E1
Catena-Dell'Osso, M2
Corsi, M1

Reviews

2 reviews available for zonisamide and Binge-Eating Disorder

ArticleYear
Novel treatment options of binge eating disorder.
    Current medicinal chemistry, 2011, Volume: 18, Issue:33

    Topics: Anticonvulsants; Binge-Eating Disorder; Fructose; Ghrelin; Humans; Isoxazoles; Narcotic Antagonists;

2011
Latest advancements in the pharmacological treatment of binge eating disorder.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:15

    Topics: Binge-Eating Disorder; Female; Fructose; Ghrelin; Humans; Isoxazoles; Topiramate; Zonisamide

2012